摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-<2-(dimethylamino)-1-ethyl>-2,3-dihydro-6-(4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-carboxamide | 112127-82-9

中文名称
——
中文别名
——
英文名称
N-<2-(dimethylamino)-1-ethyl>-2,3-dihydro-6-(4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-carboxamide
英文别名
N-(2-dimethylaminoethyl)-6-(4-oxochromen-2-yl)-2,3-dihydro-1,4-benzodioxine-2-carboxamide;N-[2-(dimethylamino)ethyl]-6-(4-oxochromen-2-yl)-2,3-dihydro-1,4-benzodioxine-2-carboxamide
N-<2-(dimethylamino)-1-ethyl>-2,3-dihydro-6-(4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-carboxamide化学式
CAS
112127-82-9
化学式
C22H22N2O5
mdl
——
分子量
394.427
InChiKey
CASYHDUKAFDWMR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    29
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    77.1
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    Ethyl 6-(4-oxo-4H-chromen-2-yl)-2,3-dihydro-1,4-benzodioxine-2-carboxylateN,N-二甲基乙二胺 反应 0.5h, 以52.1%的产率得到N-<2-(dimethylamino)-1-ethyl>-2,3-dihydro-6-(4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-carboxamide
    参考文献:
    名称:
    Synthesis of some flavone derivatives: potent inhibitors of human platelet aggregation
    摘要:
    A series of 20 benzodioxan derivatives of flavone were synthesized and characterised each bearing an ester or amide side chain of variable length. The activity of the compounds on washed human platelet aggregation induced by ADP (5-mu-M), collagen (2.5-mu-g/ml) and thrombin (0.1 U/ml) was evaluated. The ethoxycarbonyl side chain derivative inhibited all 3 types of aggregation agents with an IC50 of 1, 2, and 24-mu-M respectively, making it one of the most potent platelet aggregation inhibitors among the flavonoids. Its mode of action should involve an increase in platelet cyclic AMP.
    DOI:
    10.1016/0223-5234(91)90124-6
点击查看最新优质反应信息

文献信息

  • Synthesis of some flavone derivatives: potent inhibitors of human platelet aggregation
    作者:R Ertan、H Göker、M Ertan、A Beretz、JP Cazenave、M Haag、R Anton
    DOI:10.1016/0223-5234(91)90124-6
    日期:1991.10
    A series of 20 benzodioxan derivatives of flavone were synthesized and characterised each bearing an ester or amide side chain of variable length. The activity of the compounds on washed human platelet aggregation induced by ADP (5-mu-M), collagen (2.5-mu-g/ml) and thrombin (0.1 U/ml) was evaluated. The ethoxycarbonyl side chain derivative inhibited all 3 types of aggregation agents with an IC50 of 1, 2, and 24-mu-M respectively, making it one of the most potent platelet aggregation inhibitors among the flavonoids. Its mode of action should involve an increase in platelet cyclic AMP.
查看更多

同类化合物

红景天灵 水飞蓟素B2 水飞蓟素A,B 水飞蓟宾磷脂酰胆碱(SPC) 水飞蓟宾 水飞蓟宾 水飞木质灵 次大风子素 异水飞蓟宾B 亚聚丙基二醇,甲苯二异氰酸酯,羟基丙基甲丙烯酰酸酯聚合物 4-[(2R)-5,7-二羟基-2-[(2R)-2-(4-羟基-3-甲氧基苯基)-3-[(4-羟基-4-氧代丁酰基)氧基甲基]-2,3-二氢-1,4-苯并二氧杂环己-7-基]-4-氧代色满-3-基]氧基-4-氧代丁酸 3,7-二羟基-2-(1,4-苯并二恶烷-6-基)色满-4-酮 3,7-二羟基-2-((2,3-二苯基)-1,4-苯并二恶烷-6-基)色满-4-酮 2,3-脱氢水飞蓟宾B 2,3-脱氢水飞蓟宾A 3,4-methylene-dioxybenzoic acid mono[[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-6-(2,3-dihydro-3,5,7-trihydroxy-4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-yl]methyl] ester 5'-methoxyhydnocarpin-D 5'-methoxyhydnocarpin sinaicitin-D Silybin 23-O-β-lactoside 3,4-dimethoxybenzoic acid mono[[2,3-dihydro-3-(4-hydroxy-3-methoxy phenyl)-6-(2,3-dihydro-3,5,7-trihydroxy-4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-yl]methyl] ester 3,5-dinitrobenzoic acid mono[[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-6-(2,3-dihydro-3,5,7-trihydroxy-4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-yl]methyl] ester 3-chlorobenzoic acid mono[[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-6-(2,3-dihydro-3,5,7-trihydroxy-4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxin-2-yl]methyl] ester sodium silybin-23-O-(4-nitrophenyl)-phosphate 23-chloro-2,3-dehydrosilybin 5,7,20-O-trimethyl-2,3-dehydrosilybin 1,3,11a-trihydroxy-9-(3,5,7-trihydroxy-4H-1-benzopyran-4-on-2-yl)-5a-(3,4-dihydroxyphenyl)-5,6,11-hexahydro-5,6,11-trioxanaphthacene-12-one (+/-)-sinaiticin (10S,11S)-hydnocarpin D (2R,3R,10S,11R)-silybin silybin B 20-O-sulfate (2R,3S,10S,11S)-silybin silybin A 20-O-sulfate (2R,3S,10R,11R)-silybin (2SR*,2'R*,3'R*)-2-<2-(4-Benzyloxy-3-methoxyphenyl)-3-hydroxymethyl-1,4-benzodioxan-6-yl>-2,3-dihydro-5,7-dihydroxy-4H-benzopyran-4-one hydnocarpin-D peracetate hydnocarpin (+/-)-5'-methoxyhydnocarpin-D 5-deoxy-3-hydroxyhydnocarpin-D 3-O-pentyl-2,3-dehydrosilibinin 7-O-dihydroferuloylsilibinin silymarin Legalon SIL disodium;(2R,3R)-3-(3-carboxypropanoyloxy)-2-[(2R,3R)-2-(3-carboxypropanoyloxymethyl)-3-(3-methoxy-4-oxidophenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-7-hydroxy-4-oxo-2,3-dihydrochromen-5-olate 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5-dihydroxy-7-(cis,cis-9,12-octadecadienoyl)-oxy-4H-1-benzopyran-4-one 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-((cis,cis-9,12-octadecadienoyl)-oxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one 2-(2,3-dihydro-benzo[1,4]dioxan-6-yl)-3-hydroxy-7-benzyloxy-benzopyran-4-one 6,8-Dichloro-2-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-chromen-4-one 7-Chloro-2-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-chroman-4-one 2-<2-2-(N1,N1-Diethylaminoethyl)carboxamido>-1,4-benzodioxane-7-yl>-4H-1-benzopyran-4-one